Bringing the fundamentals into focus…
Back to NeoGenomics, Inc.
How NeoGenomics, Inc. stacks up
NEO · against 1,335 other Healthcare companies
Profitability
31/ 100
Below the middle of the pack.
Ranked #916 of 1,336 · scores higher than 31% of peers
Bars: peers in each 10-point band of the profitability score134 peers with a profitability score of 30–39, including NEO · Click a bar to see the companies
Why profitability scores 31?
Weighted metrics compared with all Healthcare companies.Mainly because of its operating margin, return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a thinner operating margin: weaker than 74% of peers. Operating margin: -8.9% vs peer median 7.1%
- a lower return on invested capital: weaker than 72% of peers. Return on invested capital: -5.3% vs peer median 4.7%
- a lower return on assets: weaker than 68% of peers. Return on assets: -3.8% vs peer median 1.7%
Metric by metric
Position: dot = NEO, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NEO | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | -5.3% | 4.7% | 28% | 33% | |
| Operating marginHigher is better · 1,251 reported | -8.9% | 7.1% | 26% | 33% | |
| Return on assetsHigher is better · 1,315 reported | -3.8% | 1.7% | 32% | 33% | |
| Return on equityHigher is better · 1,252 reported | -6.3% | 3.2% | 35% | Context only | |
| Gross marginHigher is better · 1,394 reported | 43.9% | 45.9% | 48% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NEO| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 916 | 3.5B CNY (≈$496M) | 31 | 18 | |
| 916 | 51M EUR (≈$56M) | 31 | 22 | |
| 916 | 1.1B USD | 31 | 43 | |
| 916 | 5.3B USD | 31 | 50 | |
| 916 | 2.2B USD | 31 | 36 | |
| 916 | 1.3B USD | 31 | 20 | |
| 916 | 21.7B USD | 31 | 32 | |
| 929 | 7.1B CNY (≈$993M) | 30 | 27 | |
| 929 | 3.9B HKD (≈$493M) | 30 | 66 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score